Iradimed Prices IPO At $6.25 Per Share

(RTTNews) - Iradimed Corp., the provider of non-magnetic intravenous or IV infusion pump systems that are safe for use during magnetic resonance imaging or MRI procedures, announced the pricing of its initial public offering of 2.016 million shares of its common stock at an initial public offering price of $6.25 per share for a total offering amount of $12.6 million before deducting underwriting discounts and commissions, and estimated offering expenses payable by Iradimed.

In addition, the underwriters have been granted a 45-day option to purchase up to an additional 302,400 shares of common stock at the initial public offering price solely to cover over-allotments, if any.

The shares are expected to begin trading on The NASDAQ Capital Market on July 16, 2014 under the symbol "IRMD." The closing of the offering is expected to occur on July 21, 2014, subject to customary closing conditions.

Roth Capital Partners is acting as sole book-running manager for the offering and Monarch Capital Group is acting as co-manager.